Form 4: Shalom Auerbach and Einodmil LLC No Longer Subject to Section 16 Reporting for OS Therapies Inc (OSTX)
SEC Form 4
Shalom Auerbach and Einodmil LLC ceased being 10% beneficial owners of OS Therapies Inc on May 9, 2025, and are therefore no longer subject to Section 16 reporting requirements.
Summary
- Shalom Auerbach and Einodmil LLC, collectively referred to as the 'Reporting Persons', are no longer subject to Section 16 reporting requirements.
- This change is due to the Reporting Persons ceasing to be 10% beneficial owners of OS Therapies Inc (OSTX) as of May 9, 2025.
- The determination is based on 27,202,661 shares of common stock outstanding, as reported by the Issuer.
- Consequently, the Reporting Persons will no longer file Form 4 or Form 5 for transactions in the Common Stock of the Issuer.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a regulatory filing indicating a change in ownership, not directly related to the company's performance.
Industry Context
This is a standard regulatory filing related to changes in beneficial ownership. It doesn't necessarily reflect the company's performance or future prospects, but rather the ownership structure.
Key Dates
| Date | Description |
|---|---|
| 05/09/2025 | Date that Shalom Auerbach and Einodmil LLC ceased being 10% beneficial owners of OS Therapies Inc. |
Keywords
Section 16, Form 4, Form 5, Beneficial Ownership, OS Therapies Inc, OSTX, Reporting Requirements, Shalom Auerbach, Einodmil LLC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.